Health IT

TeamUp launches its AI Business Advisor, a tool set to transform fitness studio management by turning raw business data into strategic, actionable insights.

Amesite's NurseMagic™ is a finalist for a top nursing award, validating its strategy to cut paperwork and capture a slice of the post-acute care pie.

With record 2025 revenue and a dominant hold on the gene therapy market, Cryoport's strategic investments pave a path toward profitability.

A successful Puerto Rico pilot shows how cellular RPM and culturally-aware care can control hypertension, paving the way for a national FQHC rollout.

A novel sputum test could end the trial-and-error approach for millions with chronic respiratory disease, promising a new era of personalized medicine.

A new partnership fuses marketing muscle with AI tech to launch a health platform in China, but it faces major regulatory and privacy hurdles.

With burnout and financial woes plaguing healthcare, Altera Digital Health bets on advanced AI to ease burdens and restore the human touch at HIMSS26.

A new global survey reveals a startling gap between knowing sleep is vital and getting quality rest. Technology tracks our every toss and turn, but is it helping?

A new program in a remote Ontario community aims to overcome systemic healthcare gaps, providing a vital blueprint for Indigenous health sovereignty.

A new national agreement gives thousands of U.S. hospitals streamlined access to Nanosonics' trophon3, aiming to elevate patient safety standards.

A new board certification in Disaster Medicine will equip physicians across 14 specialties to lead during crises, enhancing healthcare system resilience.

With 14% growth, strategic acquisitions, and major AI advancements, Real Chemistry is redefining healthcare commercialization on its 25th anniversary.

The EHR vendor will showcase how its 'intelligent interoperability' uses AI and patient control to move beyond compliance and create strategic advantages.

Donors granted a record $3.9 billion via Vanguard Charitable in 2025, highlighting the growing power and agility of donor-advised funds in philanthropy.

On Rare Disease Day, Polaryx Therapeutics advances a novel oral drug in a pivotal trial for four devastating pediatric disorders, offering a new strategy.

Aragon Research names LivePerson a Leader as the market shifts from chatbots to sophisticated AI agents, highlighting its focus on trust and reliability.

A new partnership aims to end pharmacy sticker shock by giving patients unprecedented control over prescription price, location, and availability.

The 3M spin-off navigates a transformative year, posting strong organic growth driven by MedSurg and Dental, despite a reported sales dip from divestitures.

With TGA approval, Optellum's AI platform arrives to help tackle Australia's low lung cancer survival rates by enabling earlier, more accurate detection.

Returning to Austin, SHE Media's Co-Lab gathers stars and experts to tackle women's health, blending advocacy with a sharp business and media strategy.